Search Results for: covid

Pandemic Pivot Pays Off

Insights MiRXES’ Pandemic Pivot Pays Off Armed with a wealth of experience from the pandemic, MiRXES is now set to return to its roots and focus on producing best-in-class multi-cancer early diagnostics. 2020 was anything but business as usual, but human ingenuity shone amid the uncertainty. Even as the coronavirus spread swiftly across the globe, …

Pandemic Pivot Pays Off Read More »

From Singapore to the world

Insights From Singapore to the world Founded with a focus on microRNA discoveries and diagnostics, MiRXES is now looking to solidify its manufacturing and delivery capabilities and help Singapore elevate its competitiveness on the global stage. Starting out as a small country with no natural resources, Singapore has since evolved into a world-class advanced manufacturing …

From Singapore to the world Read More »


WHO WE ARE Our Vision A future where all diseases are prevented or diagnosed early while they are curable. Our Mission Improving and saving lives through disease early detection tests. Who are we? Asia-centered with Global Ambitions MiRXES is a Singapore-headquartered biotechnology company whose mission is to improve and save lives through disease early detection …

Company Read More »

For Healthcare

Accurate, Actionable, and Affordable Diagnostic Solutions To enable early detection of cancer and other diseases Diagnostic solutions for cancer GASTROClear World’s first blood test for early detection of gastric cancer – Detects gastric cancer early for timely, life-saving treatment. – Developed in collaboration with the Singapore Gastric Cancer Consortium, Diagnostics Development (DxD) Hub, National University …

For Healthcare Read More »

Scroll to Top